• Google Has Released An AI Tool That Makes Sense Of Your Genome

    MIT Technology Review | AI tools could help us turn information gleaned from genetic sequencing into life-saving therapies.

    Dec 5, 2017
  • Medherant, EightSpokes, Cambridge Semantics, And More: News From November 2017

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Medherant, EightSpokes, Cambridge Semantics, and more.

    Dec 5, 2017
  • NVIDIA Extends GPU Cloud Support For AI Researchers

    Bio-IT World Brief  NVIDIA has extended NVIDIA GPU Cloud (NGC) support to NVIDIA TITAN, giving AI researchers using desktop GPUs access to NGC. The company has also added new software and other key updates to the NGC container registry to provide researchers a broader, more powerful set of tools to advance their AI and high performance computing research and development efforts.

    Dec 4, 2017
  • Deep Learning In The Clinic: Predicting Patient Prognosis

    Bio-IT World | In a paper published last month on arXiv, and not yet peer-reviewed, Stanford researchers outlined how machine learning can be made to predict prognosis in a clinical setting.

    Dec 4, 2017
  • Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace

    Bio-IT World Brief | During the AWS re:Invent, Edico Genome revealed its DRAGEN Complete Suite on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN's applications for next-generation sequencing data analysis in one click.

    Dec 1, 2017
  • AWS Adds Capabilities For Amazon Aurora And Amazon DynamoDB, Introduces Amazon Neptune

    Bio-IT World Brief | Yesterday at AWS re:Invent, Amazon Web Services (AWS) announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, a new fully managed graph database service.

    Nov 30, 2017
  • A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own

    Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.

    Nov 29, 2017
  • AI Exposes Patterns For Faster Drug Discovery

    Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.

    Nov 29, 2017